Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer

International Journal of Cancer

Volumn 89, Issue 6, 2000, Pages 514-518

  Chow, Nan Haw ^a   Cairns, Paul ^b   Eisenberger, Claus F ^a   Schoenberg, Mark P ^a   Taylor, David C ^b   Epstein, Jonathan I ^b   Sidransky, David ^a,b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER STAGING; CHROMOSOME 9Q; GENE FREQUENCY; GENE INACTIVATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; HYPERPLASIA; PRECANCER; PRIORITY JOURNAL; RECURRENT CANCER; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE; UROTHELIUM;

CARCINOMA, TRANSITIONAL CELL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 9; CLONE CELLS; DISEASE PROGRESSION; HUMANS; HYPERPLASIA; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SQUAMOUS CELL; PAPILLOMA; PRECANCEROUS CONDITIONS; REPETITIVE SEQUENCES, NUCLEIC ACID; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0034693676     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20001120)89:6<514::AID-IJC8>3.0.CO;2-H     Document Type: Article

References (38)

1. Molecular themes in oncogenesis
2. The pathogenesis of experimental bladder cancer
3. Frequency of homozygous deletion at p16/ CDKN2 in primary human tumors
4. Loss of heterozygosity at the Rb locus is frequent and correlates with muscle invasion in bladder carcinoma
5. Initiation of bladder cancer may involve deletion of a tumor suppressor gene on chromosome 9
6. Preliminary mapping of the deleted region of chromosome 9 in bladder cancer
7. Homozygous deletions of 9q21 in primary human bladder tumors detected by comparative multiplex PCR
8. Novel suppressor loci on chromosome 14q in primary bladder cancer
9. Early lesions in experimental bladder cancer: Experimental design and light microscopic findings
10. Loss of genes on the short arm of chromosome 11 in bladder cancer
11. A genetic model for colorectal tumorigenesis
12. Cancer, crash sites, and the new genetics of neoplasia
13. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma
14. A long-term study of reversible and progressive urinary bladder cancer lesions in rats fed N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide
15. Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading?
16. Allelotype of human bladder cancer
17. Tumors of the urinary bladder
18. Papilloma of the urinary bladder
19. Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assay
20. Microsatellite alterations as clonal marker for the detection of human cancer
21. Molecular detection of primary bladder cancer by microsatellite analysis
22. Papillary tumors of the bladder
23. The clonal evolution of tumor cell populations
24. Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinoma of the bladder
25. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors
26. Molecular alterations in superficial and locally advanced human bladder cancer
27. Classification and staging of bladder cancer
28. Marked genetic differences between stage pTa and stage pTl papillary bladder cancer detected by comparative genomic hybridization
29. Evidence for two bladder cancer suppressor loci on chromosome 9
30. Genesis of papillary tumours: Histological and microangiographic study
31. Clonal origin of bladder cancer
32. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations
33. Managing superficial bladder cancer: An overview
34. Two molecular pathways to transitional cell carcinoma of the bladder
35. Detection of bladder cancer recurrence by microsatellite analysis of urine
36. Papillary urothelial hyperplasia. A precursor to papillary neoplasms
37. The histogenesis of experimental bladder cancer
38. Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer